Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 653Ovarian Neoplasms 441Endometrial Neoplasms 290Breast Neoplasms 179Uterine Cervical Dysplasia 133Neoplasms 86Carcinoma, Ovarian Epithelial 80Papillomavirus Infections 69Prostatic Neoplasms 67Uterine Neoplasms 66Vulvar Neoplasms 64Colorectal Neoplasms 59Fallopian Tube Neoplasms 54Colonic Neoplasms 47Peritoneal Neoplasms 45Pancreatic Neoplasms 45Lung Neoplasms 45Urinary Bladder Neoplasms 39Vaginal Neoplasms 34Gynecologic Cancer 33Stomach Neoplasms 32Head and Neck Neoplasms 31Hereditary Breast and Ovarian Cancer Syndrome 27Sarcoma 26Rectal Neoplasms 26Pelvic Neoplasms 26Melanoma 25Esophageal Neoplasms 25Recurrence 24Ovarian Cysts 24

Interventions

Psychiatric Rehabilitation 1Methods 1Early Intervention, Educational 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leydig Cell Tumor × Gynecologic × Clear all
NCT01764789 2015-10-09

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
39 enrolled
BreastGynecologic

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Fatigue, Leydig Cell Tumor, Pain, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡